Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Poushali Bhattacharya, Neena G. Shetake, Badri N. Pandey & Amit Kumar. (2018) Receptor tyrosine kinase signaling in cancer radiotherapy and its targeting for tumor radiosensitization. International Journal of Radiation Biology 94:7, pages 628-644.
Read now
Read now
De-Sheng Wang, Hai-Chun Lai & Jian-Min Huang. (2014) Epidermal growth factor receptor mutations in Chinese patients with laryngeal squamous cell carcinoma. Acta Oto-Laryngologica 134:6, pages 631-635.
Read now
Read now
Articles from other publishers (13)
Guiqin Xie, Liang Shan, Cuicui Yang, Yuanyi Liu, Xiaowu Pang, Shaolei Teng, Tzyy-Choou Wu & Xinbin Gu. (2023) Recombinant immunotoxin induces tumor intrinsic STING signaling against head and neck squamous cell carcinoma. Scientific Reports 13:1.
Crossref
Crossref
Yagmur Kan, YiTing Paung, Yunyoung Kim, Markus A. Seeliger & W. Todd Miller. (2023) Biochemical Studies of Systemic Lupus Erythematosus-Associated Mutations in Nonreceptor Tyrosine Kinases Ack1 and Brk. Biochemistry 62:6, pages 1124-1137.
Crossref
Crossref
Christine Hoesl, Enrica Zanuttigh, Thomas Fröhlich, Julia Philippou-Massier, Stefan Krebs, Helmut Blum & Maik Dahlhoff. (2020) The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and induces tumorigenic properties. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1867:8, pages 118717.
Crossref
Crossref
Anna Kiseleva, Tim N. Beck, Ilya G. Serebriiskii, Hanqing Liu, Barbara Burtness & Erica A. Golemis. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
7
61
.
Konrad Klinghammer, James Keller, Jonathan George, Jens Hoffmann, Edward L. Chan & Michael J. Hayman. (2018) A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers. International Journal of Cancer 142:1, pages 156-164.
Crossref
Crossref
James Keller, Anjaruwee S. Nimnual, Mathew S. Varghese, Kristen A. VanHeyst, Michael J. Hayman & Edward L. Chan. (2016) A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma. Molecular Cancer Research 14:8, pages 740-752.
Crossref
Crossref
LS Monteiro, S Ricardo, ML Delgado, F Garcez, B do Amaral & C Lopes. (2014) Phosphorylated EGFR at tyrosine 1173 correlates with poor prognosis in oral squamous cell carcinomas. Oral Diseases 20:2, pages 178-185.
Crossref
Crossref
Hanqing Liu, Jennifer R. Cracchiolo, Tim N. Beck, Ilya G. Serebriiskii & Erica A. Golemis. 2014. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
55
90
.
J Keller, A S Nimnual, K R Shroyer, C Joy, I Ischenko, C S Chandler, L M Dong, M J Hayman & E L Chan. (2013) Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma. British Journal of Cancer 109:2, pages 482-492.
Crossref
Crossref
Kwang-Yu Chang, Shan-Yin Tsai, Shang-Hung Chen, Hsiao-Hui Tsou, Chia-Jui Yen, Ko-Jiunn Liu, Hsun-Lang Fang, Hung-Chang Wu, Bin-Fay Chuang, Shao-Wen Chou, Careen K Tang, Shyun-Yeu Liu, Pei-Jung Lu, Ching-Yu Yen & Jang-Yang Chang. (2013) Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance. Journal of Biomedical Science 20:1, pages 43.
Crossref
Crossref
Wan Li, Lina Chen, Xia Li, Xu Jia, Chenchen Feng, Liangcai Zhang, Weiming He, Junjie Lv, Yuehan He, Weiguo Li, Xiaoli Qu, Yanyan Zhou & Yuchen Shi. (2013) Cancer-related marketing centrality motifs acting as pivot units in the human signaling network and mediating cross-talk between biological pathways. Molecular BioSystems 9:12, pages 3026.
Crossref
Crossref
John Foley, Nicole Nickerson, David J. RieseIIII, Peter C. Hollenhorst, Gwendolen Lorch & Anne M. Foley. (2012) At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone. Odontology 100:2, pages 109-129.
Crossref
Crossref
Sarah Wheeler, Doris R. Siwak, Raymond Chai, Courtney LaValle, Raja R. Seethala, Lin Wang, Kathleen Cieply, Carol Sherer, Corwin Joy, Gordon B. Mills, Athanassios Argiris, Jill M. Siegfried, Jennifer R. Grandis & Ann Marie Egloff. (2012) Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research 18:8, pages 2278-2289.
Crossref
Crossref